Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
193.40
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AbbVie
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
58
59
Next >
Want Safety and Growth in 2023? Try These Dividend Stocks.
January 25, 2023
Passive income is particularly welcome during tough market times.
Via
The Motley Fool
Charles River Laboratories, AbbVie, Star Bulk Carriers And This Big Bank Are CNBC's 'Final Trades'
January 23, 2023
On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said Charles River Laboratories International, Inc. (NYSE: CRL) is trading at 20 time
Via
Benzinga
2 Top Passive-Income Stocks to Own in 2023
January 22, 2023
These dividend stocks can deliver both downside protection and capital appreciation.
Via
The Motley Fool
AbbVie Is Set to Lose on Its Biggest Blockbuster. Here's Why You Shouldn't Worry.
January 22, 2023
Two newer immunology drugs look like big tickets to growth.
Via
The Motley Fool
7 Stocks Every Smart Investor Should Own in 2023
January 20, 2023
At this point, the best thing to do is position your portfolio for potential downside with these top stocks to own.
Via
InvestorPlace
3 Unstoppable Stocks to Keep Buying in 2023
January 19, 2023
These companies have what it takes to drive long-term share performance.
Via
The Motley Fool
Should Investors Worry About AbbVie's Dividend?
January 10, 2023
The risks are real, but they're decreasing over time.
Via
The Motley Fool
If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today
January 09, 2023
Via
Benzinga
Immunome Stock Jumps On Discovery Pact With AbbVie
January 06, 2023
Via
Benzinga
7 Biotech Stocks That Will Make You Rich in 10 Years
January 18, 2023
Although the health innovation space is risky, the opportunities beckon a look at the biotech stocks that will make you rich in 10 years.
Via
InvestorPlace
2 Cheap Growth Stocks That Can Set You Up for Life
January 18, 2023
Over the past 10 years, these stocks have each risen by more than 340%.
Via
The Motley Fool
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
January 17, 2023
Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing.
Via
Talk Markets
Could This FDA Approval Boost AbbVie's Stock?
January 17, 2023
Last month, one of its anti-psychotic drugs received approval from the Food and Drug Administration for another indication.
Via
The Motley Fool
With Competition on the Rise, Is AbbVie's Dividend Safe?
January 17, 2023
This year isn't starting on the best of notes for the drugmaker.
Via
The Motley Fool
AbbVie, Eli Lilly Leave UK's Voluntary Medicines Pricing Agreement Over Increasing Prices
January 17, 2023
Via
Benzinga
This Monumental Breakthrough Could Turn the World Upside Down -- and Make Some Investors Filthy Rich
January 17, 2023
The fountain of youth might not be a myth in the future.
Via
The Motley Fool
Is AbbVie a Good Dividend Stock to Buy on the Dip?
January 17, 2023
The stock offers an attractive yield, but investors need to brace for declining revenue this year.
Via
The Motley Fool
5 Dividend Kings I Bought for My Portfolio
January 16, 2023
Rely upon income-generating stocks to see your portfolio through times of upheaval.
Via
The Motley Fool
Top-Performing Hedge Fund In 2022 Has This Strategy To Thank: How Much Did It Make Last Year?
January 13, 2023
Macro trading is an investment strategy that takes into account both domestic and global macroeconomic trends.
Via
Benzinga
Want to Get Richer? 3 Best Stocks to Buy Now and Hold Forever
January 13, 2023
Steady growth and dividends in an evergreen industry like healthcare can be a winning investment strategy.
Via
The Motley Fool
Peering Into AbbVie's Recent Short Interest
January 12, 2023
AbbVie's (NYSE:ABBV) short percent of float has fallen 5.19% since its last report. The company recently reported that it has 12.93 million shares sold short, which is 0.73% of all regular shares that...
Via
Benzinga
The Stocks Behind 2022's Popular ETFs
January 12, 2023
One of the most popular actively managed ETFs in 2022 for inflows was the JPMorgan Equity Premium Income ETF (JEPI). It holds 125 stocks and is currently paying a 12-month yield of 9.64%.
Via
Talk Markets
3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off
January 11, 2023
These three healthcare stocks all deliver dependable dividends, with yields of 3% or more.
Via
The Motley Fool
If You Like Dividends, You Should Love These 3 Stocks
January 11, 2023
From growth to value, these companies reward shareholders handsomely.
Via
The Motley Fool
1 Hot Growth Stock to Buy Now, and 1 to Avoid
January 11, 2023
One company is gearing up for further growth while the other stumbles over itself.
Via
The Motley Fool
3 Passive Income Stocks That Are Screaming Buys in January
January 10, 2023
All three could make investors a little bit richer every quarter.
Via
The Motley Fool
3 Top Dividend Kings to Buy for the Long Haul
January 10, 2023
It's the underlying businesses that fund their dividends that make these stocks especially attractive.
Via
The Motley Fool
3 No-Brainer Dividend Stocks to Buy in 2023
January 07, 2023
These stocks have what it takes to win over the long run.
Via
The Motley Fool
AbbVie Briefly Breaks Out After Tapping Immunome In $30 Million Cancer Deal
January 06, 2023
AbbVie is tapping Immunome to help develop new cancer treatments.
Via
Investor's Business Daily
AbbVie, Goldman Sachs And This Electric Vehicle Manufacturer On CNBC's 'Final Trades'
January 06, 2023
On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners said he was shorting Rivian Automotive Inc. (NASDAQ: RIVN) despite the stock recordi
Via
Benzinga
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
58
59
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.